A year after being greenlit, the program has yet to begin
Two new drugs offer promise after obeticholic acid misses out on full approval
The bird flu has been spreading widely since March
Shares included a stake in UnitedHealth Group worth as much as $600,000
Where medicine is all fun and games
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
News, features, and commentary about cancer-related issues
A monthly roundup of healthcare-focused AI news and research
Study also showed the monoclonal antibody was noninferior to ustekinumab
PURPOSE 2 trial affirms benefits previously proven in cisgender women
Results of FELIX study supported obecabtagene autoleucel's recent FDA approval
Agency is evaluating the need for further regulatory action
Association believed to be related to inflammation
News and commentary from the psychiatry world
New measure incorporates exacerbations and healthcare utilization
Pollution-mortality relationship evidenced at the level of PM2.5 source type
Emily Chew, MD, explains how diet and key nutrients shape AMD management strategies
More Americans are living with pain now, CDC data show
Optical assessments and machine-learning approaches allow for accurate diagnosis
A weekly roundup of healthcare's encounters with the courts
This past week in healthcare investigations
Bhattacharya was also a critic of COVID pandemic lockdowns and vaccine mandates
Health news and commentary gathered by 乌鸦传媒 staff
Also in TTHealthWatch: genetic testing of couples planning pregnancy
乌鸦传媒 reporters offer further insights into recently covered topics
Three physicians face crossroads in patient care
A discussion with the former CEO of the Bill & Melinda Gates Foundation
Craig Spencer, MD, talks about the symptoms and his treatment at Bellevue Hospital
An examination of what's driving sexual violence against women in medicine
This newly approved testing modality brings challenges and opportunities
Unequal access threatens to worsen disparities
The potential benefits of CAR T-cell therapies still far outweigh the risks